1. Home
  2. NWPX vs CRVS Comparison

NWPX vs CRVS Comparison

Compare NWPX & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NWPX

Northwest Pipe Company

HOLD

Current Price

$67.41

Market Cap

610.5M

Sector

Industrials

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$25.23

Market Cap

546.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWPX
CRVS
Founded
1966
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
610.5M
546.7M
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
NWPX
CRVS
Price
$67.41
$25.23
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$60.00
$28.00
AVG Volume (30 Days)
61.8K
7.1M
Earning Date
02-25-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
24.50
N/A
EPS
3.66
N/A
Revenue
$519,991,000.00
N/A
Revenue This Year
$8.18
N/A
Revenue Next Year
$1.02
N/A
P/E Ratio
$18.40
N/A
Revenue Growth
7.64
N/A
52 Week Low
$36.97
$2.54
52 Week High
$70.61
$26.95

Technical Indicators

Market Signals
Indicator
NWPX
CRVS
Relative Strength Index (RSI) 57.79 91.48
Support Level $66.98 $6.46
Resistance Level $70.61 $7.18
Average True Range (ATR) 2.10 1.66
MACD 0.08 2.20
Stochastic Oscillator 65.15 91.63

Price Performance

Historical Comparison
NWPX
CRVS

About NWPX Northwest Pipe Company

NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products. The Company is the manufacturer of engineered water transmission systems in North America and produces steel casing pipe, bar-wrapped concrete cylinder pipe, and pipeline system joints and fittings through its Engineered Steel Pressure Pipe segment. The Company provides solution-based products for a wide range of markets, including high-quality reinforced precast concrete products, lined precast sanitary sewer system components, water distribution and management equipment, including pump lift stations, wastewater pretreatment, and stormwater quality products through its Precast Infrastructure and Engineered Systems segment.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: